AbbVie
ABBV
#26
Rank
S$647.17 B
Marketcap
S$366.13
Share price
-0.88%
Change (1 day)
20.33%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2026 (TTM): S$16.46 Billion

According to AbbVie's latest financial reports the company's current earnings are S$66.01 Billion. In 2025 the company made an earning of S$8.51 Billion, an increase over its 2024 earnings that were of S$4.79 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$16.46 B93.28%
2025 S$8.51 B77.53%
2024 S$4.79 B-40.54%
2023 S$8.07 B-53.62%
2022 S$17.40 B3.76%
2021 S$16.77 B282.25%
2020 S$4.38 B-59.67%
2019 S$10.88 B62.13%
2018 S$6.71 B-32.74%
2017 S$9.97 B-1.99%
2016 S$10.18 B18.65%
2015 S$8.58 B180.5%
2014 S$3.05 B-55.57%
2013 S$6.88 B-6.86%
2012 S$7.39 B56.05%
2011 S$4.73 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$8.99 B-45.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$44.90 B 171.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$14.27 B-13.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$0.57 B-96.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-S$3.28 Billion-119.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$14.63 B-11.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$19.48 B 17.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$9.23 B-44.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
S$1.11 B-93.27%๐Ÿ‡บ๐Ÿ‡ธ USA